drugset

drugset / Trial / NCT01057030

Multiple Dose Japanese Bridging Study

NCT01057030 ↗

Phase 1 Completed 22 enrolled Bristol-Myers Squibb

RandomizedParallel-groupQuadruple-blind

Summary

The purpose of this study is to assess the safety and tolerability of multiple oral daily doses of BMS-708163 in healthy young male subjects

Timeline

Start: 2010-03
Primary completion: 2010-06
Completion: 2010-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Avagacestat	Small molecule	125 mg	Oral

Indications